Data as of Nov 26
| +0.73 / +1.27%|
The 40 analysts offering 12-month price forecasts for Dr.Reddy's Laboratories Ltd have a median target of 55.83, with a high estimate of 65.10 and a low estimate of 46.00. The median estimate represents a -4.14% decrease from the last price of 58.24.
The current consensus among 41 polled investment analysts is to Buy stock in Dr.Reddy's Laboratories Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.